Journal of Health Economics and Outcomes Research
image
Persistence with Early-Line Abatacept versus Tumor Necrosis Factor-Inhibitors for Rheumatoid Arthritis Complicated by Poor Prognostic Factors

DOI: 10.36469/jheor.2021.23684, Volume: 8, Issue: 1, Pages: 71-78
Article Type: research-article, Article History
https://www.researchpad.co/tools/openurl?pubtype=&doi=10.36469/jheor.2021.23684&title=Persistence with Early-Line Abatacept versus Tumor Necrosis Factor-Inhibitors for Rheumatoid Arthritis Complicated by Poor Prognostic Factors&author=&keyword=[{keywordId=336, uniqueName=rheumatoid-arthritis, name=Rheumatoid arthritis, contentId=151828}, {keywordId=10838, uniqueName=tumor-necrosis-factor-inhibitors, name=Tumor necrosis factor inhibitors, contentId=151828}, {keywordId=12874, uniqueName=disease-modifying-antirheumatic-drugs, name=disease-modifying antirheumatic drugs, contentId=151828}, {keywordId=44448, uniqueName=abatacept, name=Abatacept, contentId=151828}, {keywordId=204680, uniqueName=therapy-persistence, last=true, name=therapy persistence, contentId=151828}],[{keywordId=336, uniqueName=rheumatoid-arthritis, name=Rheumatoid arthritis, contentId=151828}, {keywordId=10838, uniqueName=tumor-necrosis-factor-inhibitors, name=Tumor necrosis factor inhibitors, contentId=151828}, {keywordId=12874, uniqueName=disease-modifying-antirheumatic-drugs, name=disease-modifying antirheumatic drugs, contentId=151828}, {keywordId=44448, uniqueName=abatacept, name=Abatacept, contentId=151828}, {keywordId=204680, uniqueName=therapy-persistence, last=true, name=therapy persistence, contentId=151828}],[{keywordId=336, uniqueName=rheumatoid-arthritis, name=Rheumatoid arthritis, contentId=151828}, {keywordId=10838, uniqueName=tumor-necrosis-factor-inhibitors, name=Tumor necrosis factor inhibitors, contentId=151828}, {keywordId=12874, uniqueName=disease-modifying-antirheumatic-drugs, name=disease-modifying antirheumatic drugs, contentId=151828}, {keywordId=44448, uniqueName=abatacept, name=Abatacept, contentId=151828}, {keywordId=204680, uniqueName=therapy-persistence, last=true, name=therapy persistence, contentId=151828}],[{keywordId=336, uniqueName=rheumatoid-arthritis, name=Rheumatoid arthritis, contentId=151828}, {keywordId=10838, uniqueName=tumor-necrosis-factor-inhibitors, name=Tumor necrosis factor inhibitors, contentId=151828}, {keywordId=12874, uniqueName=disease-modifying-antirheumatic-drugs, name=disease-modifying antirheumatic drugs, contentId=151828}, {keywordId=44448, uniqueName=abatacept, name=Abatacept, contentId=151828}, {keywordId=204680, uniqueName=therapy-persistence, last=true, name=therapy persistence, contentId=151828}],[{keywordId=336, uniqueName=rheumatoid-arthritis, name=Rheumatoid arthritis, contentId=151828}, {keywordId=10838, uniqueName=tumor-necrosis-factor-inhibitors, name=Tumor necrosis factor inhibitors, contentId=151828}, {keywordId=12874, uniqueName=disease-modifying-antirheumatic-drugs, name=disease-modifying antirheumatic drugs, contentId=151828}, {keywordId=44448, uniqueName=abatacept, name=Abatacept, contentId=151828}, {keywordId=204680, uniqueName=therapy-persistence, last=true, name=therapy persistence, contentId=151828}],&subject=